United StatesThe US health department lets pharmacies compound 6 experimental peptides, including BPC-157.
Career scientists at the US drug regulator say there is scant evidence the substances are safe or effective.
Licensed pharmacies and physicians can compound the peptides, including TB-500, without fear of federal enforcement for now.
The allowance is temporary, and the scientists’ objections stand.
How each outlet framed it
- STAT leans critical
- frames the peptide order as a regulatory reversal, setting HHS's no-enforcement policy against FDA career scientists' objections on safety evidence
Sources: STAT